Maternal levels of growth differentiation factor-15 in patients with preeclampsia

Hypertens Pregnancy. 2018 Nov;37(4):192-196. doi: 10.1080/10641955.2018.1524477. Epub 2018 Oct 6.

Abstract

Objective: Growth differentiation factor-15 (GDF-15) is a stress-induced cytokine and related to the prognosis of cardiovascular diseases. Our purpose is to measure the maternal levels of GDF-15 in patients with early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE).

Methods: This cross-sectional study was conducted including 72 pregnant women, 23 with normal pregnancies and 49 with preeclampsia (26 with EOPE and 23 with LOPE). Maternal serum levels of GDF-15 were measured by using enzyme-linked immunosorbent assay kits.

Results: The median serum GDF-15 level was found to be the highest in the EOPE group (EOPE: 441.7 pg/ml). The median serum GDF-15 levels were higher in women with preeclampsia than in the control group (309.7 pg/ml vs. 436.6 pg/ml, p: 0.009).

Conclusion: Our findings suggest GDF-15 increased as a response to endothelial injury caused by cytokines triggered by preeclampsia.

Keywords: GDF-15; Preeclampsia; cytokine; growth differentiation factor-15.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • Growth Differentiation Factor 15 / blood*
  • Humans
  • Pre-Eclampsia / blood*
  • Pregnancy
  • Pregnancy Trimester, Third / blood
  • Young Adult

Substances

  • GDF15 protein, human
  • Growth Differentiation Factor 15